Patrick R. O'Neil, EVP CLO & General Counsel at IONIS PHARMACEUTICALS INC (IONS), sold 129,328 shares at $67.69 ($8.8M) on 2025-10-02, disclosed to the SEC on 2025-10-02.
Scheduled sale ($8.8M) by EVP CLO & General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $67.69 | 30,203 | $2.0M | 23.4% |
| 2 | $67.69 | 30,203 | $2.0M | 23.4% |
| 3 | $67.69 | 34,461 | $2.3M | 26.6% |
| 4 | $67.69 | 34,461 | $2.3M | 26.6% |
| Total | $67.69 avg | 129,328 | $8.8M | 100% |
| Filing → |
| IONS | SELL | 2026-02-02 | $516K | — | Filing → |
| IONS | SELL | 2026-01-20 | $697K | — | Filing → |
| IONS | SELL | 2025-10-08 | $1.2M | — | Filing → |